Status:

UNKNOWN

Corneal Stroma Implantation for the Treatment of Keratoconus

Lead Sponsor:

Shandong Eye Hospital

Conditions:

Keratoconus

Eligibility:

All Genders

15-60 years

Phase:

NA

Brief Summary

The purpose of this study is to determine whether corneal stroma implantation is effective in the treatment of keratoconus.

Detailed Description

Keratoconus is a corneal disease with the progressive thinning of the central corneal stroma. The main treatment methods are corneal transplantation, corneal collagen cross-linking, etc. The effect of...

Eligibility Criteria

Inclusion

  • Advanced and completed keratoconus patients
  • Voluntarily signed informed consent
  • No surgery and anesthesia contraindications

Exclusion

  • Acute edema of cornea
  • Primary keratoconus patients
  • The patients combined systemic diseases
  • Reject study and follow visit
  • Cannot tolerate surgery or anesthesia

Key Trial Info

Start Date :

August 11 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2018

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT03229239

Start Date

August 11 2017

End Date

December 1 2018

Last Update

August 24 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shandong Eye Hospital

Jinan, Shandong, China